 | • レポートコード：QY2207C3841 • 出版社/出版日：QYResearch / 2022年7月11日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のGP予防接種の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にGP予防接種の世界市場のxxx％を占める「DNA」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「成人」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のGP予防接種の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのGP予防接種市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのGP予防接種市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 GP予防接種のグローバル主要メーカーには、Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi、Takis Biotech、Zydus Cadila、Codagenix、GeoVax、Bravovax、Altimmune、Vaxart、Clover Biopharmaceuticals、ImmunoPreciseなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 GP予防接種市場は、種類と用途によって区分されます。世界のGP予防接種市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 DNA、非複製ウイルスベクター、タンパク質サブユニット、RNA、その他 【用途別セグメント】 成人、子供 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - GP予防接種製品概要 - 種類別市場（DNA、非複製ウイルスベクター、タンパク質サブユニット、RNA、その他） - 用途別市場（成人、子供） - 調査の目的 ・エグゼクティブサマリー - 世界のGP予防接種販売量予測2017-2028 - 世界のGP予防接種売上予測2017-2028 - GP予防接種の地域別販売量 - GP予防接種の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別GP予防接種販売量 - 主要メーカー別GP予防接種売上 - 主要メーカー別GP予防接種価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（DNA、非複製ウイルスベクター、タンパク質サブユニット、RNA、その他） - GP予防接種の種類別販売量 - GP予防接種の種類別売上 - GP予防接種の種類別価格 ・用途別市場規模（成人、子供） - GP予防接種の用途別販売量 - GP予防接種の用途別売上 - GP予防接種の用途別価格 ・北米市場 - 北米のGP予防接種市場規模（種類別、用途別） - 主要国別のGP予防接種市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのGP予防接種市場規模（種類別、用途別） - 主要国別のGP予防接種市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のGP予防接種市場規模（種類別、用途別） - 主要国別のGP予防接種市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のGP予防接種市場規模（種類別、用途別） - 主要国別のGP予防接種市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのGP予防接種市場規模（種類別、用途別） - 主要国別のGP予防接種市場規模（トルコ、サウジアラビア） ・企業情報 Moderna、CanSino Biologicals、Inovio Pharmaceuticals、Shenzhen Geno-Immune Medical Institute、GlaxoSmithKine、Pfizer、Johnson＆Johnson、Heat Biologics、Sanofi、Takis Biotech、Zydus Cadila、Codagenix、GeoVax、Bravovax、Altimmune、Vaxart、Clover Biopharmaceuticals、ImmunoPrecise ・産業チェーン及び販売チャネル分析 - GP予防接種の産業チェーン分析 - GP予防接種の原材料 - GP予防接種の生産プロセス - GP予防接種の販売及びマーケティング - GP予防接種の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - GP予防接種の産業動向 - GP予防接種のマーケットドライバー - GP予防接種の課題 - GP予防接種の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global GP Vaccination Market
Due to the COVID-19 pandemic, the global GP Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, DNA accounting for % of the GP Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Adults segment is altered to an % CAGR throughout this forecast period.
China GP Vaccination market size is valued at US$ million in 2021, while the US and Europe GP Vaccination are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe GP Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of GP Vaccination include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global GP Vaccination Scope and Segment
GP Vaccination market is segmented by Type and by Application. Players, stakeholders, and other participants in the global GP Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Adults
Children
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Takis Biotech
Zydus Cadila
Codagenix
GeoVax
Bravovax
Altimmune
Vaxart
Clover Biopharmaceuticals
ImmunoPrecise
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 GP Vaccination Product Introduction
1.2 Market by Type
1.2.1 Global GP Vaccination Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global GP Vaccination Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global GP Vaccination Sales Estimates and Forecasts 2017-2028
2.2 Global GP Vaccination Revenue Estimates and Forecasts 2017-2028
2.3 Global GP Vaccination Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global GP Vaccination Sales by Region
2.4.1 Global GP Vaccination Sales by Region (2017-2022)
2.4.2 Global Sales GP Vaccination by Region (2023-2028)
2.5 Global GP Vaccination Revenue by Region
2.5.1 Global GP Vaccination Revenue by Region (2017-2022)
2.5.2 Global GP Vaccination Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global GP Vaccination Sales by Manufacturers
3.1.1 Global Top GP Vaccination Manufacturers by Sales (2017-2022)
3.1.2 Global GP Vaccination Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GP Vaccination in 2021
3.2 Global GP Vaccination Revenue by Manufacturers
3.2.1 Global GP Vaccination Revenue by Manufacturers (2017-2022)
3.2.2 Global GP Vaccination Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by GP Vaccination Revenue in 2021
3.3 Global GP Vaccination Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global GP Vaccination Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GP Vaccination Sales by Type
4.1.1 Global GP Vaccination Historical Sales by Type (2017-2022)
4.1.2 Global GP Vaccination Forecasted Sales by Type (2023-2028)
4.1.3 Global GP Vaccination Sales Market Share by Type (2017-2028)
4.2 Global GP Vaccination Revenue by Type
4.2.1 Global GP Vaccination Historical Revenue by Type (2017-2022)
4.2.2 Global GP Vaccination Forecasted Revenue by Type (2023-2028)
4.2.3 Global GP Vaccination Revenue Market Share by Type (2017-2028)
4.3 Global GP Vaccination Price by Type
4.3.1 Global GP Vaccination Price by Type (2017-2022)
4.3.2 Global GP Vaccination Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global GP Vaccination Sales by Application
5.1.1 Global GP Vaccination Historical Sales by Application (2017-2022)
5.1.2 Global GP Vaccination Forecasted Sales by Application (2023-2028)
5.1.3 Global GP Vaccination Sales Market Share by Application (2017-2028)
5.2 Global GP Vaccination Revenue by Application
5.2.1 Global GP Vaccination Historical Revenue by Application (2017-2022)
5.2.2 Global GP Vaccination Forecasted Revenue by Application (2023-2028)
5.2.3 Global GP Vaccination Revenue Market Share by Application (2017-2028)
5.3 Global GP Vaccination Price by Application
5.3.1 Global GP Vaccination Price by Application (2017-2022)
5.3.2 Global GP Vaccination Price Forecast by Application (2023-2028)
6 North America
6.1 North America GP Vaccination Market Size by Type
6.1.1 North America GP Vaccination Sales by Type (2017-2028)
6.1.2 North America GP Vaccination Revenue by Type (2017-2028)
6.2 North America GP Vaccination Market Size by Application
6.2.1 North America GP Vaccination Sales by Application (2017-2028)
6.2.2 North America GP Vaccination Revenue by Application (2017-2028)
6.3 North America GP Vaccination Market Size by Country
6.3.1 North America GP Vaccination Sales by Country (2017-2028)
6.3.2 North America GP Vaccination Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe GP Vaccination Market Size by Type
7.1.1 Europe GP Vaccination Sales by Type (2017-2028)
7.1.2 Europe GP Vaccination Revenue by Type (2017-2028)
7.2 Europe GP Vaccination Market Size by Application
7.2.1 Europe GP Vaccination Sales by Application (2017-2028)
7.2.2 Europe GP Vaccination Revenue by Application (2017-2028)
7.3 Europe GP Vaccination Market Size by Country
7.3.1 Europe GP Vaccination Sales by Country (2017-2028)
7.3.2 Europe GP Vaccination Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific GP Vaccination Market Size by Type
8.1.1 Asia Pacific GP Vaccination Sales by Type (2017-2028)
8.1.2 Asia Pacific GP Vaccination Revenue by Type (2017-2028)
8.2 Asia Pacific GP Vaccination Market Size by Application
8.2.1 Asia Pacific GP Vaccination Sales by Application (2017-2028)
8.2.2 Asia Pacific GP Vaccination Revenue by Application (2017-2028)
8.3 Asia Pacific GP Vaccination Market Size by Region
8.3.1 Asia Pacific GP Vaccination Sales by Region (2017-2028)
8.3.2 Asia Pacific GP Vaccination Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America GP Vaccination Market Size by Type
9.1.1 Latin America GP Vaccination Sales by Type (2017-2028)
9.1.2 Latin America GP Vaccination Revenue by Type (2017-2028)
9.2 Latin America GP Vaccination Market Size by Application
9.2.1 Latin America GP Vaccination Sales by Application (2017-2028)
9.2.2 Latin America GP Vaccination Revenue by Application (2017-2028)
9.3 Latin America GP Vaccination Market Size by Country
9.3.1 Latin America GP Vaccination Sales by Country (2017-2028)
9.3.2 Latin America GP Vaccination Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa GP Vaccination Market Size by Type
10.1.1 Middle East and Africa GP Vaccination Sales by Type (2017-2028)
10.1.2 Middle East and Africa GP Vaccination Revenue by Type (2017-2028)
10.2 Middle East and Africa GP Vaccination Market Size by Application
10.2.1 Middle East and Africa GP Vaccination Sales by Application (2017-2028)
10.2.2 Middle East and Africa GP Vaccination Revenue by Application (2017-2028)
10.3 Middle East and Africa GP Vaccination Market Size by Country
10.3.1 Middle East and Africa GP Vaccination Sales by Country (2017-2028)
10.3.2 Middle East and Africa GP Vaccination Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Corporation Information
11.1.2 Moderna Overview
11.1.3 Moderna GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Corporation Information
11.2.2 CanSino Biologicals Overview
11.2.3 CanSino Biologicals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CanSino Biologicals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CanSino Biologicals Recent Developments
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Corporation Information
11.3.2 Inovio Pharmaceuticals Overview
11.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Inovio Pharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Pharmaceuticals Recent Developments
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
11.4.2 Shenzhen Geno-Immune Medical Institute Overview
11.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Corporation Information
11.5.2 GlaxoSmithKine Overview
11.5.3 GlaxoSmithKine GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKine GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKine Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Corporation Information
11.7.2 Johnson＆Johnson Overview
11.7.3 Johnson＆Johnson GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson＆Johnson GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson＆Johnson Recent Developments
11.8 Heat Biologics
11.8.1 Heat Biologics Corporation Information
11.8.2 Heat Biologics Overview
11.8.3 Heat Biologics GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Heat Biologics GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Heat Biologics Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
11.10 Takis Biotech
11.10.1 Takis Biotech Corporation Information
11.10.2 Takis Biotech Overview
11.10.3 Takis Biotech GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takis Biotech GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takis Biotech Recent Developments
11.11 Zydus Cadila
11.11.1 Zydus Cadila Corporation Information
11.11.2 Zydus Cadila Overview
11.11.3 Zydus Cadila GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zydus Cadila GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zydus Cadila Recent Developments
11.12 Codagenix
11.12.1 Codagenix Corporation Information
11.12.2 Codagenix Overview
11.12.3 Codagenix GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Codagenix GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Codagenix Recent Developments
11.13 GeoVax
11.13.1 GeoVax Corporation Information
11.13.2 GeoVax Overview
11.13.3 GeoVax GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 GeoVax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 GeoVax Recent Developments
11.14 Bravovax
11.14.1 Bravovax Corporation Information
11.14.2 Bravovax Overview
11.14.3 Bravovax GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bravovax GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bravovax Recent Developments
11.15 Altimmune
11.15.1 Altimmune Corporation Information
11.15.2 Altimmune Overview
11.15.3 Altimmune GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Altimmune GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Altimmune Recent Developments
11.16 Vaxart
11.16.1 Vaxart Corporation Information
11.16.2 Vaxart Overview
11.16.3 Vaxart GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Vaxart GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Vaxart Recent Developments
11.17 Clover Biopharmaceuticals
11.17.1 Clover Biopharmaceuticals Corporation Information
11.17.2 Clover Biopharmaceuticals Overview
11.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Clover Biopharmaceuticals GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Clover Biopharmaceuticals Recent Developments
11.18 ImmunoPrecise
11.18.1 ImmunoPrecise Corporation Information
11.18.2 ImmunoPrecise Overview
11.18.3 ImmunoPrecise GP Vaccination Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 ImmunoPrecise GP Vaccination Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 ImmunoPrecise Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GP Vaccination Industry Chain Analysis
12.2 GP Vaccination Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GP Vaccination Production Mode & Process
12.4 GP Vaccination Sales and Marketing
12.4.1 GP Vaccination Sales Channels
12.4.2 GP Vaccination Distributors
12.5 GP Vaccination Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 GP Vaccination Industry Trends
13.2 GP Vaccination Market Drivers
13.3 GP Vaccination Market Challenges
13.4 GP Vaccination Market Restraints
14 Key Findings in The Global GP Vaccination Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer